Poster Session
P-01
Xiangjie Sun
Centers for Disease Control and Prevention
Dissecting the multifactorial roles of influenza A virus receptor binding specificity in the airborne transmission dynamics of an H9N2 virus
P-02
Marwa Akao
Nagoya University
Investigating the relationship between influenza viral dynamics and clinical symptoms using data from Phase 3 clinical trials of oseltamivir
P-03
Troy Kieran
Centers for Disease Control and Prevention
Using machine learning to identify predictive correlates in ferret in vivo model data for influenza A risk assessment.
P-04
Shotaro Yamamoto
Nagoya University
Estimation of treatment efficacy of drug candidates against mpox virus in combination
P-05
Maureen Rebecca Smith
Robert Koch-Institute
Genome-based incidence estimation of SARS-CoV-2 with GInPipe
P-06
Daiki Tatematsu
Nagoya University
Detection of changes in viral load in a randomized controlled trial of an anti-SARS-CoV-2 drug with high entry inhibition efficacy.
P-07
Sharmin Nahar Sithi
Kumamoto University
Establishment of recombinant HIV with timer fluorescence protein to visualize virus transcription
P-08
Takara Nishiyama
Nagoya University
Quantitative analysis of the antiviral effect of mucosal antibodies to suppress infectious SARS-CoV-2 shedding.
P-10
Kosaku Kitagawa
Nagoya University
Simulating booster vaccinations: a case study of Fukushima Vaccination Cohort
P-11
Hyeongki Park
Nagoya University
Heterogeneity in duration of viral shedding in COVID-19 patient fs saliva may not be explained by basic clinical and micro-RNA information
P-12
Mizuka Komatsu
Kobe University
Algebra-assisted PINN approach for SEIR modeling with unobserved variables
P-13
Yong Dam Jeong
Nagoya University
Effective screening with antigen tests for identifying COVID-19 patients: simulation with viral dynamics model
P-14
Jun Koseki
Nagoya University
Analysis of antiviral drug resistance caused by amino acid mutations
P-15
Choi Sooyoun
Nagoya University/ Pusan National University
Prediction of the indicator for determining immune reconstruction syndrome (IRIS)-induced hepatic flare (HF) in HBV/HIV co-infected patients
P-16
Ryuichi Kumata
The Graduate University of Advanced Studies, SOKENDAI
Evolutionary dynamics of virulence of helper and satellite viruses
P-17
Joohyeon Woo
Nagoya University
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2
P-18
Yusuke Asai
National Center for Global Health and Medicine
Estimating the effect of medical intervention on the arrival time of infectious diseases
P-19
Megumi Oya
RIKEN
An interpretable machine learning framework for monitoring and stratifying the time-varying prognostic risk of diseases
P-20
Kyoko Kojima
Nagoya University
Public relations strategies for the non-scientific community in virus dynamics research
P-21
Yoshitaka Sato
Nagoya University Graduate School of Medicine
Heterogeneity of individual B lymphocytes during transformation by Epstein-Barr virus infection
P-22
Takeru Matsuura
Nagoya University
A machine learning model for predicting hepatocarcinogenesis in chronic hepatitis B patients
P-23
Shoya Iwanami
Nagoya University
Quantification of age-related changes in hematopoietic stem cell differentiation